Annual EBITDA
-$143.99 M
-$274.38 M-210.43%
December 31, 2023
Summary
- As of March 2, 2025, ITOS annual EBITDA is -$143.99 million, with the most recent change of -$274.38 million (-210.43%) on December 31, 2023.
- During the last 3 years, ITOS annual EBITDA has fallen by -$105.22 million (-271.37%).
- ITOS annual EBITDA is now -156.31% below its all-time high of $255.69 million, reached on December 31, 2021.
Performance
ITOS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$47.69 M
-$35.25 M-283.35%
September 30, 2024
Summary
- As of March 2, 2025, ITOS quarterly EBITDA is -$47.69 million, with the most recent change of -$35.25 million (-283.35%) on September 30, 2024.
- Over the past year, ITOS quarterly EBITDA has dropped by -$10.68 million (-28.84%).
- ITOS quarterly EBITDA is now -122.22% below its all-time high of $214.63 million, reached on December 31, 2021.
Performance
ITOS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$142.33 M
-$5.68 M-4.16%
September 30, 2024
Summary
- As of March 2, 2025, ITOS TTM EBITDA is -$142.33 million, with the most recent change of -$5.68 million (-4.16%) on September 30, 2024.
- Over the past year, ITOS TTM EBITDA has increased by +$1.54 million (+1.07%).
- ITOS TTM EBITDA is now -133.77% below its all-time high of $421.41 million, reached on June 30, 2022.
Performance
ITOS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ITOS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -210.4% | -28.8% | +1.1% |
| 3 y3 years | -271.4% | -158.8% | -635.5% |
| 5 y5 years | -724.0% | -633.5% | -528.1% |
ITOS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -156.3% | at low | -122.2% | at low | -133.8% | +14.0% |
| 5 y | 5-year | -156.3% | at low | -122.2% | at low | -133.8% | +14.0% |
| alltime | all time | -156.3% | at low | -122.2% | at low | -133.8% | +14.0% |
ITeos Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$47.69 M(+283.4%) | -$142.33 M(+4.2%) |
| Jun 2024 | - | -$12.44 M(-72.5%) | -$136.64 M(-17.4%) |
| Mar 2024 | - | -$45.18 M(+22.0%) | -$165.41 M(+15.0%) |
| Dec 2023 | -$143.99 M(-210.4%) | -$37.02 M(-11.9%) | -$143.87 M(+63.7%) |
| Sep 2023 | - | -$42.01 M(+1.9%) | -$87.86 M(+46.1%) |
| Jun 2023 | - | -$41.21 M(+74.4%) | -$60.16 M(+301.7%) |
| Mar 2023 | - | -$23.63 M(-224.5%) | -$14.98 M(-111.5%) |
| Dec 2022 | $130.39 M(-49.0%) | $18.99 M(-232.8%) | $130.39 M(-60.0%) |
| Sep 2022 | - | -$14.30 M(-460.3%) | $326.03 M(-22.6%) |
| Jun 2022 | - | $3.97 M(-96.7%) | $421.41 M(+7.8%) |
| Mar 2022 | - | $121.74 M(-43.3%) | $391.07 M(+52.9%) |
| Dec 2021 | $255.69 M | $214.63 M(+164.7%) | $255.68 M(+862.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $81.07 M(-407.5%) | $26.58 M(-140.7%) |
| Jun 2021 | - | -$26.37 M(+93.2%) | -$65.31 M(+41.7%) |
| Mar 2021 | - | -$13.65 M(-5.7%) | -$46.07 M(+18.8%) |
| Dec 2020 | -$38.77 M(+71.1%) | -$14.48 M(+33.9%) | -$38.77 M(+27.4%) |
| Sep 2020 | - | -$10.81 M(+51.5%) | -$30.44 M(+16.5%) |
| Jun 2020 | - | -$7.13 M(+12.4%) | -$26.13 M(+8.9%) |
| Mar 2020 | - | -$6.35 M(+3.4%) | -$24.00 M(+5.9%) |
| Dec 2019 | -$22.66 M(+29.7%) | -$6.14 M(-5.5%) | -$22.66 M(+37.2%) |
| Sep 2019 | - | -$6.50 M(+29.9%) | -$16.52 M(+64.9%) |
| Jun 2019 | - | -$5.00 M(-0.1%) | -$10.01 M(+99.9%) |
| Mar 2019 | - | -$5.01 M | -$5.01 M |
| Dec 2018 | -$17.48 M | - | - |
FAQ
- What is iTeos Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for iTeos Therapeutics?
- What is iTeos Therapeutics annual EBITDA year-on-year change?
- What is iTeos Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly EBITDA year-on-year change?
- What is iTeos Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for iTeos Therapeutics?
- What is iTeos Therapeutics TTM EBITDA year-on-year change?
What is iTeos Therapeutics annual EBITDA?
The current annual EBITDA of ITOS is -$143.99 M
What is the all time high annual EBITDA for iTeos Therapeutics?
iTeos Therapeutics all-time high annual EBITDA is $255.69 M
What is iTeos Therapeutics annual EBITDA year-on-year change?
Over the past year, ITOS annual EBITDA has changed by -$274.38 M (-210.43%)
What is iTeos Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ITOS is -$47.69 M
What is the all time high quarterly EBITDA for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly EBITDA is $214.63 M
What is iTeos Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ITOS quarterly EBITDA has changed by -$10.68 M (-28.84%)
What is iTeos Therapeutics TTM EBITDA?
The current TTM EBITDA of ITOS is -$142.33 M
What is the all time high TTM EBITDA for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM EBITDA is $421.41 M
What is iTeos Therapeutics TTM EBITDA year-on-year change?
Over the past year, ITOS TTM EBITDA has changed by +$1.54 M (+1.07%)